Founder and Executive Chairman of Emergent BioSolutions Announces Retirement

3 years ago

Fuad El-Hibri to Retire After More Than 20 YearsGAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:…

AirPhysio For COPD Symptoms – Treatment And Reviews YouTube Channel Launched

3 years ago

Life Wellness Healthcare has launched a YouTube channel discussing topics related to respiratory health, COPD, and reviews for the AirPhysio…

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

3 years ago

Daix (France), Long Island City (New York), January 14, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…

Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China

3 years ago

BURLINGAME, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (NASDAQ: CRVS), a clinical-stage biopharmaceutical…

Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference

3 years ago

DEERFIELD, Ill., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on…

Celsion Corporation Announces Pricing of $30 Million Registered Direct Offerings of Convertible Redeemable Preferred Stock

3 years ago

LAWRENCEVILLE, N.J., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy…

Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics Landscape

3 years ago

Live webcast will be at 8:30 a.m. EST on January 25OXFORD, United Kingdom, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Vaccitech…

InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants

3 years ago

InteliSwab test With less than one minute of “hands-on time,” the InteliSwab test is as simple as “Swab, Swirl, and…

Galapagos creates new subscription right plan

3 years ago

Mechelen, Belgium; 13 January 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its supervisory…

REPEAT — Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company

3 years ago

-A greater than 50% reduction in SARS-CoV-2 Delta viral load was observed- -REVTx-99 was tested prior to infection in multiple…